Financials
Income statement
| Fiscal date | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total reported revenue | 86.4B | 78.3B | 50.5B |
| Cost of revenue | 27.4B | 27.7B | 27.2B |
| Gross profit | 59.0B | 50.7B | 23.3B |
| Operating expense | |||
| Research & development | — | — | — |
| Selling general and admin | 13.8B | 11.4B | 5.0B |
| Other operating expenses | 452.3M | 565.1M | 1.7B |
| Operating income | 18.7B | 21.2B | 9.2B |
| Non operating interest income | |||
| Income | 48.5M | 24.4M | 131.9M |
| Expense | 411.2M | 713.9M | 14.8M |
| Other income expense | — | — | — |
| Pretax income | 18.8B | 19.9B | 9.4B |
| Tax provision | 4.7B | 4.8B | 2.4B |
| Net income | 14.0B | 15.1B | 7.1B |
| Basic EPS | 10.0 | 11.0 | 5.1 |
| Diluted EPS | 10.0 | 11.0 | 5.1 |
| Basic average shares | 1.4B | 1.4B | 1.4B |
| Diluted average shares | 1.4B | 1.4B | 1.4B |
| EBITDA | 22.0B | 22.9B | 10.2B |
| Net income from continuing op. | — | — | — |
| Minority interests | -346.9M | 0 | 0 |
| Preferred stock dividends | 0 | 0 | 0 |